1.
Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study
by Laakso, M
Diabetologia, 2007-12-14, Vol.51 (3), p.502-511
2.
Glucose Homeostasis and Safety in Patients with Acromegaly Converted from Long-Acting Octreotide to Pegvisomant
by Barkan, Ariel L
The journal of clinical endocrinology and metabolism, 2005-10, Vol.90 (10), p.5684-5691
3.
4.
Development of SGLT1 and SGLT2 inhibitors
by Rieg, Timo
Diabetologia, 2018-08-22, Vol.61 (10), p.2079-2086
5.
Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
by Ghezzi, Chiara
Diabetologia, 2018-08-22, Vol.61 (10), p.2087-2097
6.
Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats
by PALM, F
Diabetologia, 2004, Vol.47 (7), p.1223-1231
7.
The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
by Thomas, Merlin C
Diabetologia, 2018-08-22, Vol.61 (10), p.2098-2107
8.
Better vascular engraftment and function in pancreatic islets transplanted without prior culture
by OLSSON, R
Diabetologia, 2005, Vol.48 (3), p.469-476
9.
No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor : Fc fusion protein in obese insulin-resistant pati...
by PAQUOT, N
The journal of clinical endocrinology and metabolism, 2000, Vol.85 (3), p.1316-1319
10.
11.
The fetal glucose steal: an underappreciated phenomenon in diabetic pregnancy
by Desoye, Gernot
Diabetologia, 2016-03-19, Vol.59 (6), p.1089-1094
12.
Intensive glucose control and macrovascular outcomes in type 2 diabetes
by Turnbull, F. M
Diabetologia, 2009-08-05, Vol.52 (11), p.2288-2298
13.
Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters
by Murphy, Helen R
Diabetologia, 2019-06-03, Vol.62 (7), p.1123-1128
14.
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
by Lavalle-González, F. J
Diabetologia, 2013-09-13, Vol.56 (12), p.2582-2592
15.
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
by Scaroni, Carla
Endocrine reviews, 2017-06-01, Vol.38 (3), p.189-219
16.
SGLT2 Inhibitors May Predispose to Ketoacidosis
by Taylor, Simeon I
The journal of clinical endocrinology and metabolism, 2015-08, Vol.100 (8), p.2849-2852
17.
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease : sites and mechanisms
by BUGIANESI, E
Diabetologia, 2005, Vol.48 (4), p.634-642
18.
Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
by Cederberg, Henna
Diabetologia, 2015-03-10, Vol.58 (5), p.1109-1117
19.
Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome
by Fleseriu, Maria
The journal of clinical endocrinology and metabolism, 2012-06, Vol.97 (6), p.2039-2049
20.
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
by Verma, Subodh
Diabetologia, 2018-08-22, Vol.61 (10), p.2108-2117
Filter electronic articles 8.893 Hits
Remove Filters
- Subjects
- Endocrinology & Metabolism
- Science & Technology (8.873)
- Life Sciences & Biomedicine (8.873)
- more ...